Radioimmunotherapy

A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma

Malik Juweid, Gerald L. DeNardo, Michael Graham, Julie Marie Vose

Research output: Contribution to journalEditorial

8 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)673-674
Number of pages2
JournalCancer Biotherapy and Radiopharmaceuticals
Volume18
Issue number5
DOIs
StatePublished - Jan 1 2003

Fingerprint

CD20 Antigens
Radioimmunotherapy
Phase III Clinical Trials
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
Monoclonal Antibodies
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Pharmacology
  • Cancer Research

Cite this

Radioimmunotherapy : A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma. / Juweid, Malik; DeNardo, Gerald L.; Graham, Michael; Vose, Julie Marie.

In: Cancer Biotherapy and Radiopharmaceuticals, Vol. 18, No. 5, 01.01.2003, p. 673-674.

Research output: Contribution to journalEditorial

Juweid, Malik ; DeNardo, Gerald L. ; Graham, Michael ; Vose, Julie Marie. / Radioimmunotherapy : A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma. In: Cancer Biotherapy and Radiopharmaceuticals. 2003 ; Vol. 18, No. 5. pp. 673-674.
@article{6156e7ace87742e7960c60ab11c8bb66,
title = "Radioimmunotherapy: A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma",
author = "Malik Juweid and DeNardo, {Gerald L.} and Michael Graham and Vose, {Julie Marie}",
year = "2003",
month = "1",
day = "1",
doi = "10.1089/108497803770418229",
language = "English (US)",
volume = "18",
pages = "673--674",
journal = "Cancer Biotherapy and Radiopharmaceuticals",
issn = "1084-9785",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Radioimmunotherapy

T2 - A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma

AU - Juweid, Malik

AU - DeNardo, Gerald L.

AU - Graham, Michael

AU - Vose, Julie Marie

PY - 2003/1/1

Y1 - 2003/1/1

UR - http://www.scopus.com/inward/record.url?scp=0242413854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242413854&partnerID=8YFLogxK

U2 - 10.1089/108497803770418229

DO - 10.1089/108497803770418229

M3 - Editorial

VL - 18

SP - 673

EP - 674

JO - Cancer Biotherapy and Radiopharmaceuticals

JF - Cancer Biotherapy and Radiopharmaceuticals

SN - 1084-9785

IS - 5

ER -